Overall rank by patents
#4,637
Across all tracked assignees
USPTO PatentsView assignee record - 76 granted patents across 17 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B65G (TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS).
The verdict
OPEX holds 76 US patents across 17 technology areas, rank #4,637 of 50,000 tracked assignees.
OPEX Corporation has been granted 76 US utility patents between 2015 and 2025, placing OPEX Corporation at rank #4,637 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.6 claims per patent with primary concentration in B65G (TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS). As a US Corporation, OPEX Corporation is one of the more focused assignees in the PatentsView dataset. By volume, OPEX sits between Meiji Seika Pharma Co., Ltd. (76 patents, rank #4,633) and Samson Aktiengesellschaft (76 patents, rank #4,641) - the closest US assignees by grant volume. The composite Innovation Score of 56.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 65 grants, compared with 11 in the 2015–2019 window, a +491% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. OPEX Corporation's 18.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark OPEX Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MEIJI SEIKA PHARMA CO., LTD.
76 patents
Medtronic Advanced Energy LLC
76 patents
NANJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS
76 patents
NUVECTRA CORPORATION
76 patents
Paris Presents Incorporated
76 patents
Preferred Networks, Inc.
76 patents
Rochester Institute of Technology
76 patents
SAMSON AKTIENGESELLSCHAFT
76 patents
OPEX Corporation
76 patents
What this shows OPEX holds 76 patents at rank #4,637, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,637 in granted patent volume.
Other assignees with the most granted patents in OPEX's primary technology class.
OPEX's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
56 Top 6% higher than 94% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 2.6% |
| 2016 | 1 | 1.3% |
| 2017 | 3 | 3.9% |
| 2018 | 3 | 3.9% |
| 2019 | 2 | 2.6% |
| 2020 | 12 | 15.8% |
| 2021 | 5 | 6.6% |
| 2022 | 11 | 14.5% |
| 2023 | 14 | 18.4% |
| 2024 | 19 | 25.0% |
| 2025 | 4 | 5.3% |
Top 15 of 17 technology areas
Overall rank by patents
#4,637
Across all tracked assignees
56.2 out of 100
How to use this portfolio
OPEX's 76 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.